abstract |
The present invention relates to a selective inhibitor of phosphoinositide (PI) 3-kinase β, the use of the selective inhibitor in antithrombotic therapy, and novel detection by detecting the selective inhibitory activity of PI3-kinase β possessed by a compound. The present invention relates to a screening method for compounds useful for antithrombotic therapy. The invention further relates to novel compounds that are inhibitors of PI3-kinase. |